Danielsson K, Olah J, Zohori-Zangeneh R, Nylander E, Ebrahimi M. Increased expression of p16 in both oral and genital lichen planus. Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e449-53.  

 

 

doi:10.4317/medoral.22432

http://dx.doi.org/doi:10.4317/medoral.22432

­­­­­­­­­­­­­­­­________________________________________________________________________________

 

1. Ebrahimi M1, Wahlin YB, Coates PJ, Wiik A, Roos G, Nylander K. Detection of antibodies against p63 and p73 isoforms in sera from patients diagnosed with oral lichen planus. J Oral Pathol Med. 2007;36:93-8.
https://doi.org/10.1111/j.1600-0714.2007.00504.x
PMid:17238971

 

2. Danielsson K, Ebrahimi M, Wahlin YB, Nylander K, Boldrup L. Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol. 2012;26:1415-9.
https://doi.org/10.1111/j.1468-3083.2011.04306.x
PMid:22017396

 

3. Danielsson K, Boldrup L, Rentoft M, Coates PJ, Ebrahimi M, Nylander E, et al. Autoantibodies and decreased expression of the transcription factor ELF-3 together with increased chemokine pathways support an autoimmune phenotype and altered differentiation in lichen planus located in oral mucosa. J Eur Acad Dermatol Venereol. 2013; 27:1410-6.
https://doi.org/10.1111/jdv.12027
PMid:23134363

 

4. Montebugnoli L, Venturi M, Gissi DB, Leonardi E, Farnedi A, Foschini MP. Immunohistochemical expression of p16(INK4A) protein in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:222-7.
https://doi.org/10.1016/j.tripleo.2011.02.029
PMid:21612953

 

5. Ebrahimi M, Lundqvist L, Wahlin YB, Nylander E. Mucosal lichen planus, a systemic disease requiring multidisciplinary care: a cross-sectional clinical review from a multidisciplinary perspective. J Low Genit Tract Dis. 2012;16:377-80.
https://doi.org/10.1097/LGT.0b013e318247a907
PMid:22622344

 

6. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007:36:575-80.
https://doi.org/10.1111/j.1600-0714.2007.00582.x
PMid:17944749

 

7. van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der Waal I. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:307-10.
https://doi.org/10.1016/S1079-2104(99)70033-8

 

8. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med. 2002;13:390-6.
https://doi.org/10.1177/154411130201300503
PMid:12393758

 

9. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-7.
https://doi.org/10.1038/366704a0
PMid:8259215

 

10. Sgaramella N, Coates PJ, Strindlund K, Loljung L, Colella G, Laurell G, et al., Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. Br J Cancer. 2015;113:321-6.
https://doi.org/10.1038/bjc.2015.207
PMid:26057450 PMCid:PMC4506391

 

11. Goel S, Khurana N, Marwah A, Gupta S. Expression of cdk4 and p16 in Oral Lichen Planus. J Oral Maxillofac Res. 2015;6:e4.
https://doi.org/10.5037/jomr.2015.6204
PMid:26229583 PMCid:PMC4516856

 

12. Salehinejad J, Sharifi N, Amirchaghmaghi M, Ghazi N, Shakeri MT, Ghazi A. Immunohistochemical expression of p16 protein in oral squamous cell carcinoma and lichen planus. Ann Diagn Pathol. 2014;18:210-3.
https://doi.org/10.1016/j.anndiagpath.2014.03.009
PMid:24850170

 

13. Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J. Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy. J Oral Pathol Med. 2011;40:294-9.
https://doi.org/10.1111/j.1600-0714.2010.01001.x
PMid:21426400

 

14. Cunningham LL Jr, Pagano GM, Li M, Tandon R, Holm SW, White DK, et al. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:77-81.
https://doi.org/10.1016/j.tripleo.2005.11.028
PMid:16831676

 

15. Bradley KT, Budnick SD, Logani S. Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity. Mod Pathol. 2006;19:1310-6.
https://doi.org/10.1038/modpathol.3800649
PMid:16799478

 

16. Detre S, Saclani Jotti G, Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995;48:876-8.
https://doi.org/10.1136/jcp.48.9.876
PMid:7490328 PMCid:PMC502883

 

17. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:612-627.
https://doi.org/10.1016/j.oooo.2017.12.011
PMid:29396319

 

18. Mannweiler S, Sygulla S, Winter E, Regauer S. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression. J Am Acad Dermatol. 2013;69:73-81.
https://doi.org/10.1016/j.jaad.2012.12.973
PMid:23474228

 

19. Regauer S, Reich O, Eberz B. Vulvar cancers in women with vulvar lichen planus: a clinicopathological study. J Am Acad Dermatol. 2014;71:698-707.
https://doi.org/10.1016/j.jaad.2014.05.057
PMid:24999271

 

20. Schmitz ML, Kracht M. Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression. Trends Pharmacol Sci. 201637:101-113.
https://doi.org/10.1016/j.tips.2015.10.004

 

21. Loizou C, Laurell G, Lindquist D, Öfverman C, Stefansson K, Nylander K, et al. Incidence of tonsillar cancer in northern Sweden: Impact of human papilloma virus. Oncol Lett. 2015;10:3565-3572.
https://doi.org/10.3892/ol.2015.3775
PMid:26788170 PMCid:PMC4665991

 

22. Montebugnoli L, Gissi DB, Scapoli L, Palmieri A, Morandi L, Manelli I, Foschini MP. p16(INK4) expression is not associated with human papillomavirus in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:694-702.
https://doi.org/10.1016/j.oooo.2014.09.004
PMid:25457887

 

23. Lu R, Zhang J, Sun W, Du G, Zhou G. Inflammation-related cytokines in orallichen planus: an overview. J Oral Pathol Med. 2015;44:1-14.
https://doi.org/10.1111/jop.12142
PMid:24329772

 

24. Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, Garinis GA, Karameris A. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med. 2004;33:386-90.
https://doi.org/10.1111/j.1600-0714.2004.00221.x
PMid:15250829

 

25. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines in oral lichen planus. J Oral Pathol Med. 2003;32:77-83.
https://doi.org/10.1034/j.1600-0714.2003.00077.x
PMid:12542829

 

26. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.
https://doi.org/10.1155/2014/149185
PMid:24901008 PMCid:PMC4036716

 

27. Lebrec H, Ponce R, Preston BD, Iles J, Born TL, Hooper M. Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk. Curr Med Res Opin. 2015;31:557-74.
https://doi.org/10.1185/03007995.2015.1011778
PMid:25651481

 

28. Harvat BL, Jetten AM. Decreased growth inhibitory responses of squamous carcinoma cells to interferon-gamma involve failure to recruit cki proteins into cdk2 complexes. J Invest Dermatol. 2001;117:1274-81.
https://doi.org/10.1046/j.0022-202x.2001.01495.x
PMid:11710944

 

29. Satgunaseelan L, Virk SA, Lum T, Gao K, Clark JR, Gupta R. p16 expression independent of human papillomavirus is associated with lower stage and longer disease-free survival in oral cavity squamous cell carcinoma. Pathology. 2016;48:441-8.
https://doi.org/10.1016/j.pathol.2016.03.015
PMid:27370365

 

30. Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck. 2009;31:1544-56.
https://doi.org/10.1002/hed.21126
PMid:19424974

 

31. Natarajan E, Omobono JD 2nd, Guo Z, Hopkinson S, Lazar AJ, Brenn T, et al. A keratinocyte hypermotility/growth-arrest response involvinglaminin 5 and p16INK4A activated in wound healing and senescence. Am J Pathol. 2006;168:1821-37.
https://doi.org/10.2353/ajpath.2006.051027
PMid:16723698 PMCid:PMC1606631